XML 17 R15.htm IDEA: XBRL DOCUMENT v3.20.1
Note 9 - Income Taxes
3 Months Ended
Mar. 31, 2020
Notes to Financial Statements  
Income Tax Disclosure [Text Block]
NOTE
9:
     INCOME TAXES
 
The Company’s foreign subsidiary, Tantaline CVD ApS incurred a loss of approximately
$122,000
for the
three
months ended
March 31, 2020
which would provide a
$27,000
deferred tax asset, based on the standard corporate tax rate of
22%
in Denmark. For the
three
months ended
March 31, 2019
Tantaline CVD ApS incurred a loss of
$79,000
which would provide a
$17,000
deferred tax asset. However, sufficient uncertainty exists as to the realizability of these assets such that a full valuation allowance has been necessary.
 
For the year ended
December 31, 2019,
the Company has provided a full valuation allowance against all of the net deferred tax assets in the amount of
$2,497,414.
This was based on management’s assessment, including the last
two
years of operating losses, that it is more likely than
not
that the net deferred tax assets
may
not
be realized in the future. On
March 27, 2020,
the Coronavirus Aid, Relief and Economic Security Act (the “CARES Act”) was enacted by the United States Congress. As a result of the enactment of the CARES Act, net operating losses (“NOL’s”) can now be carried back for
five
years and resulted in the Company recognizing approximately
$1.5
million of a tax receivable. We continue to evaluate for potential utilization of the Company’s deferred tax asset, which has been fully reserved for, on a quarterly basis, reviewing our economic models, including projections and timing of orders, the commencement of operations of the new CVD Materials segment and cost containment measures.